Zobrazeno 1 - 10
of 52
pro vyhledávání: '"OSMAN İNAN"'
Autor:
Funda EREN, Esra FIRAT OĞUZ, Salim NEŞELİOĞLU, Rıdvan FIRAT, Osman İNAN, Emin GEMCİOĞLU, Enes ŞAHİNER, İhsan ATEŞ, Özcan EREL
Publikováno v:
Ahi Evran Medical Journal, Vol 6, Iss 3, Pp 337-342 (2022)
Purpose: Smoking is an important risk factor for both the onset and poor prognosis for respiratory tract infections, chronic obstructive pulmonary disease, and lung cancer. There are no clear data on the relationship of COVID-19 to smoking status. In
Externí odkaz:
https://doaj.org/article/5f40734f717b492db98cf5b1e61d1b8c
Short-Term Effect of Sodium Glucose Co – Transporter 2 Inhibitors on Routine Laboratory Examinations
Autor:
Osman İnan, Enes Şahiner
Publikováno v:
Journal of Contemporary Medicine, Vol 12, Iss 4, Pp 553-558 (2022)
Backgroundː In this study, we aimed to examine the effect of Sodium Glucose Cotransporter 2 inhibitors (SGLT-2i) on routine laboratory test results at 12 weeks of follow-up among type 2 diabetes mellitus (T2D) patients using empagliflozin and dapagl
Externí odkaz:
https://doaj.org/article/cf3f6cd0ea9a4c2ab366db512a37da5c
Autor:
Ahmet Omma, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Güven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ates Kara, Ihsan Ates
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as in individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac and TURKOVAC vaccines used as a booster dose after Co
Externí odkaz:
https://doaj.org/article/8c21a7499126460eb2a45f3715e4845c
Autor:
Hatice Kilic, Emine Arguder, Aysegul Karalezli, Ebru Unsal, Rahmet Guner, Bircan Kayaslan, İmran Hasanoglu, İhsan Ates, Musa Civak, Esmehan Akpınar, Ebru Parlak, Filiz Sadi, Yasin Kocaman, Sibel Günay, Esra Metan, Mukremin Er, Aynil Dalkıran, Habibe Hezer, Hülya Ergüden, Zeynep Hancıoğlu, Ayşe Kalem, Fatma Eser, Adalet Aypak, Esragül Akıncı, Selma Karahmetoğlu, Emin Gemcioglu, Emra Kalkan, Osman İnan, Abdulrezzak Yilmaz, Bagdagul Güler, Esra Çopuroğlu, İşil Turan, Derya Gökmen, Serhat Hayme, Aziz Ahmet Surel
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundThe aim of the study is to assess the effect of chronic lung disease on mortality in patients hospitalized with the diagnosis of prevariant COVID-19 Pneumonia compared to patients without chronic lung disease.Research design and methodsA co
Externí odkaz:
https://doaj.org/article/f1e64985467c4a5bbaf6b36186be32b3
Autor:
Ihsan Ates, Ayse Batirel, Mehtap Aydin, Fatma Yilmaz Karadag, Abdulsamet Erden, Orhan Kucuksahin, Berkan Armagan, Serdar Can Guven, Ozlem Karakas, Selim Gokdemir, Lutfiye Nilsun Altunal, Aslihan Ayse Buber, Emin Gemcioglu, Oguzhan Zengin, Osman Inan, Enes Seyda Sahiner, Gulay Korukluoglu, Zafer Sezer, Aykut Ozdarendeli, Ahmet Omma, Ates Kara
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1234 (2023)
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) immunogenicity results of the double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT049799
Externí odkaz:
https://doaj.org/article/de676a2951d24c999afea7276d33f31e
Autor:
Rahmet Guner, Bircan Kayaaslan, Imran Hasanoglu, Adalet Aypak, Hurrem Bodur, Ihsan Ates, Esragul Akinci, Deniz Erdem, Fatma Eser, Seval Izdes, Ayse Kaya Kalem, Aliye Bastug, Aysegul Karalezli, Aziz Ahmet Surel, Muge Ayhan, Selma Karaahmetoglu, Isıl Ozkocak Turan, Emine Arguder, Burcu Ozdemir, Mehmet Nevzat Mutlu, Yesim Aybar Bilir, Elif Mukime Sarıcaoglu, Derya Gokcinar, Sibel Gunay, Bedia Dinc, Emin Gemcioglu, Ruveyda Bilmez, Omer Aydos, Dilek Asilturk, Osman Inan, Turan Buzgan
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Early identification of severe COVID-19 patients who will need intensive care unit (ICU) follow-up and providing rapid, aggressive supportive care may reduce mortality and provide optimal use of medical resources. We aimed to deve
Externí odkaz:
https://doaj.org/article/6dfd8772b10f42ce86b5f417552f585e
Publikováno v:
Ankara City Hospital Medical Journal. 2:45-50
Publikováno v:
Ankara City Hospital Medical Journal. 2:69-75
Autor:
Emin GEMCİOĞLU, Salih BAŞER, Osman İNAN, Emra ASFUROGLU KALKAN, Bagdagul GULER, Selma KARAAHMETOĞLU, İmran HASANOĞLU, Rahmet GÜNER, Esra COPUROGLU, İhsan ATEŞ
Publikováno v:
Volume: 5, Issue: 2 374-378
Journal of Health Sciences and Medicine
Journal of Health Sciences and Medicine
Aim: COVID-19 is an epidemic communicable disease that has been declared as a pandemic caused by severe acute respiratory syndrome coronavirus 2. Clinical studies have demonstrated that advanced age and comorbid conditions enhance the severity of the
Autor:
Osman İNAN, Enes ŞAHİNER
Publikováno v:
Volume: 5, Issue: 2 619-624
Journal of Health Sciences and Medicine
Journal of Health Sciences and Medicine
Aim: We planned this study to examine whether the measures taken against COVID-19 infection during the pandemic and COVID-19 vaccination process raise awareness about influenza and pneumococcal vaccines for patients in the risk group. Material and Me